nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis
|
Shree, Tanaya |
|
|
|
1 |
p. 130-142 |
artikel |
2 |
ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura
|
Sakai, Kazuya |
|
|
|
1 |
p. 131-140 |
artikel |
3 |
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment
|
Serra, Sara |
|
|
|
1 |
p. 47-61 |
artikel |
4 |
Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III
|
Bakhtiar, Shahrzad |
|
|
|
1 |
p. 262-273 |
artikel |
5 |
100 Already?
|
Negrin, Robert S. |
|
|
|
1 |
p. 274 |
artikel |
6 |
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry
|
Du, Zhaohui |
|
|
|
1 |
p. 181-190 |
artikel |
7 |
A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia
|
Al-Samkari, Hanny |
|
|
|
1 |
p. 9-18 |
artikel |
8 |
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma
|
Ikeda, Daisuke |
|
|
|
1 |
p. 37-46 |
artikel |
9 |
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia
|
Ragaini, Simone |
|
|
|
1 |
p. 87-99 |
artikel |
10 |
An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1
|
Al-Harbi, Sayer |
|
|
|
1 |
p. 229-238 |
artikel |
11 |
A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
|
Lazaryan, Aleksandr |
|
|
|
1 |
p. 259-269 |
artikel |
12 |
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant
|
Dandoy, Christopher E. |
|
|
|
1 |
p. 1-11 |
artikel |
13 |
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study
|
Visco, Carlo |
|
|
|
1 |
p. 327-338 |
artikel |
14 |
A robust approach for the generation of functional hematopoietic progenitor cell lines to model leukemic transformation
|
Doma, Eszter |
|
|
|
1 |
p. 39-53 |
artikel |
15 |
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease
|
James, Paula D. |
|
|
|
1 |
p. 280-300 |
artikel |
16 |
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease
|
Connell, Nathan T. |
|
|
|
1 |
p. 301-325 |
artikel |
17 |
Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study
|
Lynggaard, Line Stensig |
|
|
|
1 |
p. 138-147 |
artikel |
18 |
Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis
|
Esham, Kimberly S. |
|
|
|
1 |
p. 19-27 |
artikel |
19 |
Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation
|
Sajulga, Ray |
|
|
|
1 |
p. 270-280 |
artikel |
20 |
Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL
|
Akahane, Koshi |
|
|
|
1 |
p. 212-224 |
artikel |
21 |
A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms
|
Hamulyák, Eva N. |
|
|
|
1 |
p. 113-121 |
artikel |
22 |
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases
|
Ratnasingam, Sumita |
|
|
|
1 |
p. 31-35 |
artikel |
23 |
Bruscaggin A, Terzi di Bergamo L, Spina V, et al. Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab. Blood Adv. 2021;5(22):4674-4685.
|
|
|
|
|
1 |
p. 159-161 |
artikel |
24 |
Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults
|
Lin, Richard J. |
|
|
|
1 |
p. 12-20 |
artikel |
25 |
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216
|
Gress, Verena |
|
|
|
1 |
p. 112-129 |
artikel |
26 |
CD61 identifies a superior population of aged murine HSCs and is required to preserve quiescence and self-renewal
|
Skinder, Natalia |
|
|
|
1 |
p. 99-111 |
artikel |
27 |
CD36 regulates factor VIII secretion from liver endothelial cells
|
Reventun, Paula |
|
|
|
1 |
p. 143-149 |
artikel |
28 |
Characterizing epigenetic aging in an adult sickle cell disease cohort
|
Lê, Brandon M. |
|
|
|
1 |
p. 47-55 |
artikel |
29 |
Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells
|
Lim, Karen Phaik Har |
|
|
|
1 |
p. 87-99 |
artikel |
30 |
Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia
|
Harvey, Richard C. |
|
|
|
1 |
p. 218-228 |
artikel |
31 |
Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial
|
Hamadani, Mehdi |
|
|
|
1 |
p. 93-98 |
artikel |
32 |
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection
|
Minniti, Caterina P. |
|
|
|
1 |
p. 207-215 |
artikel |
33 |
Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement
|
Nardi, Valentina |
|
|
|
1 |
p. 106-111 |
artikel |
34 |
Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1–infected Hodgkin and Reed-Sternberg–like cells
|
Karube, Kennosuke |
|
|
|
1 |
p. 198-206 |
artikel |
35 |
Comparing super-utilizers and lower-utilizers among commercial- and Medicare-insured adults with sickle cell disease
|
MacEwan, Sarah R. |
|
|
|
1 |
p. 224-233 |
artikel |
36 |
Concizumab: a novel anti-TFPI therapeutic for hemophilia
|
Shapiro, Amy D. |
|
|
|
1 |
p. 279 |
artikel |
37 |
Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists
|
Stojkov, Igor |
|
|
|
1 |
p. 1-12 |
artikel |
38 |
Creating an international network for science and clinical progress: democratizing dissemination of advances in global hematology
|
Kean, Leslie S. |
|
|
|
1 |
p. 275-276 |
artikel |
39 |
Deciphering racial disparities in multiple myeloma outcomes
|
Bertrand, Kimberly A. |
|
|
|
1 |
p. 234-235 |
artikel |
40 |
Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears
|
Kockwelp, Jacqueline |
|
|
|
1 |
p. 70-79 |
artikel |
41 |
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant
|
Nauffal, Mary |
|
|
|
1 |
p. 181-188 |
artikel |
42 |
Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies
|
Bagratuni, Tina |
|
|
|
1 |
p. 189-199 |
artikel |
43 |
Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factor
|
Grover, Steven P. |
|
|
|
1 |
p. 207-216 |
artikel |
44 |
Distinguishing STAT3/STAT5B-mutated large granular lymphocyte leukemia from myeloid neoplasms by genetic profiling
|
Kavesh, Mark |
|
|
|
1 |
p. 40-45 |
artikel |
45 |
Dual inhibition of the MEK/ERK and PI3K/AKT pathways prevents pulmonary GVHD suppressing perivenulitis and bronchiolitis
|
Muranushi, Hiroyuki |
|
|
|
1 |
p. 106-121 |
artikel |
46 |
Dynamic changes in murine erythropoiesis from birth to adulthood: implications for the study of murine models of anemia
|
Chen, Lixiang |
|
|
|
1 |
p. 16-25 |
artikel |
47 |
Eμ and 3′RR transcriptional enhancers of the IgH locus cooperate to promote c-myc–induced mature B-cell lymphomas
|
Ghazzaui, Nour |
|
|
|
1 |
p. 28-39 |
artikel |
48 |
Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies
|
van den Broek, Brigitte T.A. |
|
|
|
1 |
p. 49-60 |
artikel |
49 |
Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma
|
Kuhnl, Andrea |
|
|
|
1 |
p. 321-326 |
artikel |
50 |
Editorial Board
|
|
|
|
|
1 |
p. i |
artikel |
51 |
Editorial Board
|
|
|
|
|
1 |
p. i |
artikel |
52 |
Editorial Board
|
|
|
|
|
1 |
p. i |
artikel |
53 |
Editorial Board
|
|
|
|
|
1 |
p. i |
artikel |
54 |
Editorial Board
|
|
|
|
|
1 |
p. i |
artikel |
55 |
Editorial Board
|
|
|
|
|
1 |
p. i |
artikel |
56 |
Editorial Board
|
|
|
|
|
1 |
p. i |
artikel |
57 |
Exosomal regulation of lymphocyte homing to the gut
|
Park, Eun Jeong |
|
|
|
1 |
p. 1-11 |
artikel |
58 |
Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas
|
Liu, Xia |
|
|
|
1 |
p. 141-153 |
artikel |
59 |
Extended clinical and genetic spectrum associated with biallelic RTEL1 mutations
|
Touzot, Fabien |
|
|
|
1 |
p. 36-46 |
artikel |
60 |
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice
|
Kattula, Sravya |
|
|
|
1 |
p. 25-35 |
artikel |
61 |
First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma
|
Diez-Feijóo, Ramón |
|
|
|
1 |
p. 162-166 |
artikel |
62 |
Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma
|
Santoro, Armando |
|
|
|
1 |
p. 136-140 |
artikel |
63 |
Fluorescent labeling of CRISPR/Cas9 RNP for gene knockout in HSPCs and iPSCs reveals an essential role for GADD45b in stress response
|
Nasri, Masoud |
|
|
|
1 |
p. 63-71 |
artikel |
64 |
Front Matter
|
|
|
|
|
1 |
p. ii |
artikel |
65 |
Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association
|
Oishi, Naoki |
|
|
|
1 |
p. 178-189 |
artikel |
66 |
Geographic prevalence variation and phenotype penetrance in porphyria: insights from a Chinese population database
|
Li, Pei |
|
|
|
1 |
p. 12-15 |
artikel |
67 |
Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging
|
Klei, T.R.L. |
|
|
|
1 |
p. 14-24 |
artikel |
68 |
Goldmann L, Duan R, Kragh T, et al. Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT? Blood Adv. 2019;3(23):4021-4033.
|
|
|
|
|
1 |
p. 112 |
artikel |
69 |
Granulocytic myeloid-derived suppressor cells to prevent and treat murine immune-mediated bone marrow failure
|
Feng, Xingmin |
|
|
|
1 |
p. 73-86 |
artikel |
70 |
GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets
|
Chen, Xi |
|
|
|
1 |
p. 76-86 |
artikel |
71 |
Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature
|
Brignardello-Petersen, Romina |
|
|
|
1 |
p. 228-237 |
artikel |
72 |
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
|
Wieduwilt, Matthew J. |
|
|
|
1 |
p. 339-357 |
artikel |
73 |
Hematologic complications with age in Shwachman-Diamond syndrome
|
Furutani, Elissa |
|
|
|
1 |
p. 297-306 |
artikel |
74 |
Hematologic indices in individuals with pathogenic germline DICER1 variants
|
Vasta, Lauren M. |
|
|
|
1 |
p. 216-223 |
artikel |
75 |
Hemoglobin variants identified in the Uganda Sickle Surveillance Study
|
Schaefer, Beverly A. |
|
|
|
1 |
p. 93-100 |
artikel |
76 |
Hereditary folate malabsorption due to a mutation in the external gate of the proton-coupled folate transporter SLC46A1
|
Aluri, Srinivas |
|
|
|
1 |
p. 61-68 |
artikel |
77 |
Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms
|
Marsh, Judith C.W. |
|
|
|
1 |
p. 36-48 |
artikel |
78 |
HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment
|
Martens, Kylee L. |
|
|
|
1 |
p. 167-175 |
artikel |
79 |
Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
|
Bagacean, Cristina |
|
|
|
1 |
p. 207-211 |
artikel |
80 |
Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C
|
Cornish, Alex J. |
|
|
|
1 |
p. 21-32 |
artikel |
81 |
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma
|
Baird, John H. |
|
|
|
1 |
p. 143-155 |
artikel |
82 |
Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma
|
Liang, Zhiyu |
|
|
|
1 |
p. 293-296 |
artikel |
83 |
Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG
|
Turki, Amin T. |
|
|
|
1 |
p. 28-36 |
artikel |
84 |
Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma
|
Paiva, Bruno |
|
|
|
1 |
p. 219-223 |
artikel |
85 |
Impaired formation of neutrophil extracellular traps in patients with MDS
|
Brings, Carolin |
|
|
|
1 |
p. 129-137 |
artikel |
86 |
Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti
|
Alvarez, Ofelia A. |
|
|
|
1 |
p. 14-22 |
artikel |
87 |
Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15
|
Fernandez, Rafael Alonso |
|
|
|
1 |
p. 9-19 |
artikel |
88 |
Inducible Sbds deletion impairs bone marrow niche capacity to engraft donor bone marrow after transplantation
|
Zha, Ji |
|
|
|
1 |
p. 108-120 |
artikel |
89 |
Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2
|
Wu, Wenjun |
|
|
|
1 |
p. 185-197 |
artikel |
90 |
Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia
|
Wynne, Joseph |
|
|
|
1 |
p. 96-104 |
artikel |
91 |
Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia
|
Simoes, Catia |
|
|
|
1 |
p. 167-173 |
artikel |
92 |
Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis
|
Chai, Khai Li |
|
|
|
1 |
p. 20-31 |
artikel |
93 |
Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro
|
Liu, Zhi-Jian |
|
|
|
1 |
p. 13-27 |
artikel |
94 |
Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial
|
Lizarralde-Iragorri, Maria A. |
|
|
|
1 |
p. 172-182 |
artikel |
95 |
JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β
|
Yan, Yuhan |
|
|
|
1 |
p. 200-206 |
artikel |
96 |
KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemia
|
Arede, Liliana |
|
|
|
1 |
p. 165-180 |
artikel |
97 |
Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347.
|
|
|
|
|
1 |
p. 75 |
artikel |
98 |
Lin28b regulates age-dependent differences in murine platelet function
|
Stolla, Massiel Chavez |
|
|
|
1 |
p. 72-82 |
artikel |
99 |
Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia
|
Robbins, Daniel J. |
|
|
|
1 |
p. 80-92 |
artikel |
100 |
Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia
|
Rai, Parul |
|
|
|
1 |
p. 89-98 |
artikel |
101 |
Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations
|
Zhang, Haiyu |
|
|
|
1 |
p. 190-194 |
artikel |
102 |
Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy
|
Gill, Joan Cox |
|
|
|
1 |
p. 100-105 |
artikel |
103 |
Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience
|
Béranger, Nicolas |
|
|
|
1 |
p. 183-193 |
artikel |
104 |
Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
|
Illidge, Tim M. |
|
|
|
1 |
p. 203-206 |
artikel |
105 |
Medullary stromal cells synergize their production and capture of CCL21 for T-cell emigration from neonatal mouse thymus
|
James, Kieran D. |
|
|
|
1 |
p. 99-112 |
artikel |
106 |
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma
|
Chow, Victor A. |
|
|
|
1 |
p. 37-45 |
artikel |
107 |
Membrane curvature and PS localize coagulation proteins to filopodia and retraction fibers of endothelial cells
|
Carman, Christopher V. |
|
|
|
1 |
p. 60-72 |
artikel |
108 |
Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis
|
Stewart, Lauren K. |
|
|
|
1 |
p. 127-135 |
artikel |
109 |
microRNA-22 promotes megakaryocyte differentiation through repression of its target, GFI1
|
Weiss, Cary N. |
|
|
|
1 |
p. 33-46 |
artikel |
110 |
MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen
|
Ali, Haris |
|
|
|
1 |
p. 83-95 |
artikel |
111 |
Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3− T cells represents a potential antitumor mechanism of azacitidine
|
Lamprianidou, Eleftheria |
|
|
|
1 |
p. 129-142 |
artikel |
112 |
MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia
|
Foppen, Wouter |
|
|
|
1 |
p. 113-121 |
artikel |
113 |
Navigating a new terrain: how Twitter is changing hematologists
|
Zaidi, Ahmar U. |
|
|
|
1 |
p. 277-278 |
artikel |
114 |
Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia
|
Shimony, Shai |
|
|
|
1 |
p. 23-36 |
artikel |
115 |
New developments in the management of sickle cell disease
|
Thompson, Alexis A. |
|
|
|
1 |
p. 3 |
artikel |
116 |
Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors
|
Shanmugam, Vignesh |
|
|
|
1 |
p. 71-83 |
artikel |
117 |
Obesity and neoplasms of lymphohematopoietic cells
|
Lichtman, Marshall A. |
|
|
|
1 |
p. 101-103 |
artikel |
118 |
Orally bioavailable BTK PROTAC active against wild-type and C481 mutant BTKs in human lymphoma CDX mouse models
|
Lim, Ye Seul |
|
|
|
1 |
p. 92-105 |
artikel |
119 |
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials
|
Valtis, Yannis K. |
|
|
|
1 |
p. 72-81 |
artikel |
120 |
Overcoming resistance to targeted therapies in chronic lymphocytic leukemia
|
Skånland, Sigrid S. |
|
|
|
1 |
p. 334-343 |
artikel |
121 |
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
|
Frigault, Matthew J. |
|
|
|
1 |
p. 122-126 |
artikel |
122 |
Phosphoproteomics and morphology of stored human red blood cells treated by protein tyrosine phosphatases inhibitor
|
Bardyn, Manon |
|
|
|
1 |
p. 1-13 |
artikel |
123 |
Piezo1-xerocytosis red cell metabolome shows impaired glycolysis and increased hemoglobin oxygen affinity
|
Kiger, Laurent |
|
|
|
1 |
p. 84-88 |
artikel |
124 |
Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT Biobank
|
Betensky, Marisol |
|
|
|
1 |
p. 233-239 |
artikel |
125 |
Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism
|
Edvardsen, Magnus S. |
|
|
|
1 |
p. 224-232 |
artikel |
126 |
Platelet α-granules contribute to organ-specific pathologies in a mouse model of severe malaria
|
Darling, Thayer K. |
|
|
|
1 |
p. 1-8 |
artikel |
127 |
Platelets and hemostasis: a new perspective on an old subject
|
Brass, Lawrence F. |
|
|
|
1 |
p. 5-9 |
artikel |
128 |
Platelets as immune-sensing cells
|
Kapur, Rick |
|
|
|
1 |
p. 10-14 |
artikel |
129 |
Polarized mitochondria as guardians of NK cell fitness
|
Surace, Laura |
|
|
|
1 |
p. 26-38 |
artikel |
130 |
Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia
|
Cines, Douglas B. |
|
|
|
1 |
p. 62-74 |
artikel |
131 |
Postibrutinib relapse outcomes for patients with marginal zone lymphoma
|
Epperla, Narendranath |
|
|
|
1 |
p. 88-91 |
artikel |
132 |
Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post–unrelated HCT
|
Wang, Yiwen |
|
|
|
1 |
p. 66-70 |
artikel |
133 |
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
|
Shah, Urvi A. |
|
|
|
1 |
p. 236-247 |
artikel |
134 |
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia
|
Wakita, Satoshi |
|
|
|
1 |
p. 238-247 |
artikel |
135 |
Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma
|
Merz, Maximilian |
|
|
|
1 |
p. 1-9 |
artikel |
136 |
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11
|
Ishikawa, Yuichi |
|
|
|
1 |
p. 66-75 |
artikel |
137 |
Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy
|
Peres, Lauren C. |
|
|
|
1 |
p. 251-259 |
artikel |
138 |
Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort
|
Chiche, Edmond |
|
|
|
1 |
p. 176-184 |
artikel |
139 |
Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination
|
Valsecchi, Carla |
|
|
|
1 |
p. 174-177 |
artikel |
140 |
Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia
|
Inamoto, Yoshihiro |
|
|
|
1 |
p. 40-46 |
artikel |
141 |
Resistance to PRMT5-targeted therapy in mantle cell lymphoma
|
Long, Mackenzie Elizabeth |
|
|
|
1 |
p. 150-163 |
artikel |
142 |
Risk of posthospital venous thromboembolism in patients with COVID-19 varies by SARS-CoV-2 period and vaccination status
|
Roubinian, Nareg H. |
|
|
|
1 |
p. 141-144 |
artikel |
143 |
Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin
|
Politikos, Ioannis |
|
|
|
1 |
p. 191-202 |
artikel |
144 |
Seidizadeh O, Baronciani L, Pagliari MT, et al. Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2. Blood Adv. 2022; 6(13):4031-4040.
|
|
|
|
|
1 |
p. 87 |
artikel |
145 |
Should we avoid heparin to eliminate HIT?
|
Arepally, Gowthami Morey |
|
|
|
1 |
p. 4 |
artikel |
146 |
Shrinking the divide: improving myeloma CART access
|
Nooka, Ajay K. |
|
|
|
1 |
p. 248-250 |
artikel |
147 |
Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia
|
Herishanu, Yair |
|
|
|
1 |
p. 148-151 |
artikel |
148 |
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults
|
Johnston, Hannah |
|
|
|
1 |
p. 164-171 |
artikel |
149 |
Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease
|
Vedula, Rahul S. |
|
|
|
1 |
p. 54-60 |
artikel |
150 |
Structural analysis of platelet fragments and extracellular vesicles produced by apheresis platelets during storage
|
De Paoli, Silvia H. |
|
|
|
1 |
p. 207-218 |
artikel |
151 |
Successful treatment with fingolimod of graft-versus-host disease of the central nervous system
|
Gauthier, Jordan |
|
|
|
1 |
p. 10-13 |
artikel |
152 |
Supramaximal calcium signaling triggers procoagulant platelet formation
|
Abbasian, Nima |
|
|
|
1 |
p. 154-164 |
artikel |
153 |
Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature
|
Brignardello-Petersen, Romina |
|
|
|
1 |
p. 121-128 |
artikel |
154 |
Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells
|
Witt, Russell G. |
|
|
|
1 |
p. 69-74 |
artikel |
155 |
Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities
|
Morgan, Elizabeth A. |
|
|
|
1 |
p. 84-92 |
artikel |
156 |
Targeted deep sequencing in polycythemia vera and essential thrombocythemia
|
Tefferi, Ayalew |
|
|
|
1 |
p. 21-30 |
artikel |
157 |
Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells
|
Best, Scott |
|
|
|
1 |
p. 51-62 |
artikel |
158 |
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study
|
Oleshko, Olga |
|
|
|
1 |
p. 122-130 |
artikel |
159 |
TA-TMA: state of the art for diagnosis and treatment
|
Dvorak, Christopher C. |
|
|
|
1 |
p. 217 |
artikel |
160 |
αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies
|
de Witte, Moniek A. |
|
|
|
1 |
p. 240-249 |
artikel |
161 |
TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders
|
Merli, Pietro |
|
|
|
1 |
p. 281-292 |
artikel |
162 |
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation
|
Frerichs, Kristine A. |
|
|
|
1 |
p. 194-206 |
artikel |
163 |
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes
|
Gurnari, Carmelo |
|
|
|
1 |
p. 100-107 |
artikel |
164 |
The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans
|
Han, Lulu |
|
|
|
1 |
p. 46-61 |
artikel |
165 |
The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials
|
Bagacean, Cristina |
|
|
|
1 |
p. 225-227 |
artikel |
166 |
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia
|
Sun, Clare |
|
|
|
1 |
p. 145-158 |
artikel |
167 |
The incidence of cancer-associated thrombosis is increasing over time
|
Mahajan, Anjlee |
|
|
|
1 |
p. 307-320 |
artikel |
168 |
The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker
|
Lo Presti, Caroline |
|
|
|
1 |
p. 156-166 |
artikel |
169 |
The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia
|
Cunningham, Alan |
|
|
|
1 |
p. 56-69 |
artikel |
170 |
Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura
|
Zheng, Liang |
|
|
|
1 |
p. 75-83 |
artikel |
171 |
The severe spontaneous bleeding phenotype in a novel hemophilia A rat model is rescued by platelet FVIII expression
|
Shi, Qizhen |
|
|
|
1 |
p. 55-65 |
artikel |
172 |
The use of luspatercept for thalassemia in adults
|
Cappellini, Maria Domenica |
|
|
|
1 |
p. 326-333 |
artikel |
173 |
Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients
|
Cook, Michael R. |
|
|
|
1 |
p. 32-39 |
artikel |
174 |
Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression
|
Stratmann, Svea |
|
|
|
1 |
p. 152-164 |
artikel |
175 |
Treatment of congenital thrombocytopenia and decreased collagen reactivity in G6b-B–deficient mice
|
Mazharian, Alexandra |
|
|
|
1 |
p. 46-59 |
artikel |
176 |
Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections
|
Lounder, Dana T. |
|
|
|
1 |
p. 47-50 |
artikel |
177 |
Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT
|
Badar, Talha |
|
|
|
1 |
p. 47-54 |
artikel |
178 |
Truncation of 3′ CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma
|
Maekawa, Fumiyo |
|
|
|
1 |
p. 61-65 |
artikel |
179 |
Tryptophan metabolism is dysregulated in individuals with Fanconi anemia
|
Bartlett, Allison L. |
|
|
|
1 |
p. 250-261 |
artikel |
180 |
U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes
|
Komrokji, Rami |
|
|
|
1 |
p. 1-8 |
artikel |
181 |
UCD with MCD-like inflammatory state: surgical excision is highly effective
|
Zhang, Miao-yan |
|
|
|
1 |
p. 122-128 |
artikel |
182 |
Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months
|
Lew, Thomas E. |
|
|
|
1 |
p. 165-173 |
artikel |
183 |
Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19
|
Zlamal, Jan |
|
|
|
1 |
p. 248-258 |
artikel |
184 |
von Willebrand factor binding to myosin assists in coagulation
|
Flood, Veronica H. |
|
|
|
1 |
p. 174-180 |
artikel |
185 |
von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis
|
Kalot, Mohamad A. |
|
|
|
1 |
p. 62-71 |
artikel |
186 |
Welcome to Blood Advances
|
Negrin, Robert S. |
|
|
|
1 |
p. 1 |
artikel |
187 |
Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity
|
Fernández-Rodríguez, Concepción |
|
|
|
1 |
p. 82-86 |
artikel |
188 |
YY1 controls Eμ-3′RR DNA loop formation and immunoglobulin heavy chain class switch recombination
|
Mehra, Parul |
|
|
|
1 |
p. 15-20 |
artikel |